Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.72 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.70 |
| ▸ | IP6K2 | Q9UHH9 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | USP2 | O75604 | 2/20 | 0.70 |
| ▸ | TP53 | P04637 | 2/20 | 0.70 |
| ▸ | MAOB | P27338 | 2/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.70 |
| ▸ | FLT3 | P36888 | 2/20 | 0.70 |
| ▸ | NPC1 | O15118 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 7'',4'''-Dimethylamentoflavone SCHEMBL27350631 | 1.00 | APP (0.72) | APPMEN1KMT2ACYP1B1MAPT | |
| Heveaflavone SCHEMBL27350698 | 0.96 | APP (0.72) | APPMEN1KMT2ACYP1B1MAPT | |
| Heveaflavone SCHEMBL30646163 | 0.96 | APP (0.72) | APPMEN1KMT2ACYP1B1MAPT | |
| Kayaflavone SCHEMBL27350697 | 0.94 | MEN1 (0.71) | APPMEN1KMT2ACYP1B1MAPT | |
| Kayaflavone SCHEMBL30646162 | 0.94 | MEN1 (0.71) | APPMEN1KMT2ACYP1B1MAPT | |
| Sotetsuflavone SCHEMBL4467051 | 0.94 | APP (0.80) | APPMEN1KMT2ACYP1B1MAPT | |
| Sotetsuflavone SCHEMBL30646165 | 0.94 | APP (0.80) | APPMEN1KMT2ACYP1B1MAPT | |
| Podocarpusflavone A SCHEMBL29496316 | 0.92 | MEN1 (0.72) | APPMEN1KMT2ACYP1B1MAPT | |
| Podocarpusflavone A SCHEMBL25937932 | 0.92 | MEN1 (0.72) | APPMEN1KMT2ACYP1B1MAPT | |
| SCHEMBL22459584 | 0.90 | MAPT (0.77) | APPMEN1KMT2ACYP1B1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250228814-A1 | COMBINATION THERAPIES FOR THE TREATMENT OF VIRAL INFECTIONS | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2025-07-17 | — | — | US | disclosed |
| WO-2023250111-A1 | COMBINATION THERAPIES FOR THE TREATMENT OF VIRAL INFECTIONS | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2023-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228814-A1 | COMBINATION THERAPIES FOR THE TREATMENT OF VIRAL INFECTIONS | HAVCR2, EIF2AK2, MAVS | APP 3207/4885MEN1 3073/4885KMT2A 3798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.